We are live on ! Find out more
ICM

ISZO Capital Management Portfolio holdings

AUM $2M
1-Year Est. Return 35.61%
This Fund
S&P 500
This Quarter Est. Return
+75.01%
1 Year Est. Return
+35.61%
3 Year Est. Return
+68.24%
5 Year Est. Return
+471.73%
10 Year Est. Return
–
AUM
$275M
AUM Growth
+$63.2M
Cap. Flow
-$25M
Cap. Flow %
-9.07%
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
–
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
ATEX icon
Anterix
ATEX
+$6.33M
2
PTGX icon
Protagonist Therapeutics
PTGX
+$3.1M
3
CHS
Chicos FAS, Inc.
CHS
+$89.2K

Top Sells

Rank Stock Value
1
DMTK
DermTech, Inc. Common Stock
DMTK
+$30.1M
2
NTP
Nam Tai Property Inc.
NTP
+$3.27M
3
NOTV
Inotiv
NOTV
+$1.17M

Sector Composition

Rank Sector Weight
1 Real Estate 51.61%
2 Healthcare 42.43%
3 Consumer Discretionary 3.16%
4 Communication Services 2.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTP
1
DELISTED
Nam Tai Property Inc.
NTP
$142M 51.61%
5,129,590
-155,829
-3% -$3.27M
CDMO
2
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$60.2M 21.86%
2,346,961
– –
DMTK
3
DELISTED
DermTech, Inc. Common Stock
DMTK
$45.3M 16.46%
1,090,254
-732,140
-40% -$30.1M
XPEL icon
4
XPEL
XPEL
$1.22B
$8.71M 3.16%
103,860
– –
ATEX icon
5
Anterix
ATEX
$1.81B
$7.58M 2.75%
+126,311
New +$6.33M
NOTV
6
DELISTED
Inotiv
NOTV
$7.12M 2.59%
266,880
-46,642
-15% -$1.17M
PTGX icon
7
Protagonist Therapeutics
PTGX
$8.79B
$4.21M 1.53%
+93,883
New +$3.1M
CHS
8
DELISTED
Chicos FAS, Inc.
CHS
$136K 0.05%
+20,690
New +$89.2K

Similar funds

LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

ISZO Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, ISZO Capital Management held 8 positions worth $275M, up 30% from $212M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ISZO Capital Management withdrew a net $25M in Q2 2021, reducing 3 holdings. Its largest reduction was DermTech, Inc. Common Stock, cutting an estimated $30.1M.

By sector, the portfolio is most concentrated in Real Estate at 52% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, ISZO Capital Management opened a new position in Anterix worth $7.58M.

  • ISZO Capital Management's largest Q2 2021 buy was Anterix: 126,311 shares worth $7.58M.
  • ISZO Capital Management's biggest Q2 2021 reduction was DermTech, Inc. Common Stock, cutting an estimated $30.1M.
  • ISZO Capital Management's ten largest holdings make up 100% of its $275M portfolio in Q2 2021.
  • ISZO Capital Management opened 3 new positions and closed 0 in Q2 2021.
  • ISZO Capital Management's portfolio value rose 30% quarter-over-quarter to $275M.

Based on ISZO Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.